BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 18489523)

  • 1. Differential expression of angiopoietin-2 and vascular endothelial growth factor in androgen-independent prostate cancer models.
    Tesan T; Gustavsson H; Welén K; Damber JE
    BJU Int; 2008 Sep; 102(8):1034-9. PubMed ID: 18489523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiopoietin-2 is related to tumor angiogenesis in gastric carcinoma: possible in vivo regulation via induction of proteases.
    Etoh T; Inoue H; Tanaka S; Barnard GF; Kitano S; Mori M
    Cancer Res; 2001 Mar; 61(5):2145-53. PubMed ID: 11280779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment and characterization of androgen-independent human prostate cancer cell lines, LN-REC4 and LNCaP-SF, from LNCaP.
    Iwasa Y; Mizokami A; Miwa S; Koshida K; Namiki M
    Int J Urol; 2007 Mar; 14(3):233-9. PubMed ID: 17430262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the angopoietin-1, angopoietin-2, Tie2, and vascular endothelial growth factor gene in epithelial ovarian cancer.
    Hata K; Nakayama K; Fujiwaki R; Katabuchi H; Okamura H; Miyazaki K
    Gynecol Oncol; 2004 Apr; 93(1):215-22. PubMed ID: 15047239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of the antiangiogenic ability of linomide by androgen ablation involves down-regulation of vascular endothelial growth factor in human androgen-responsive prostatic cancers.
    Joseph IB; Isaacs JT
    Cancer Res; 1997 Mar; 57(6):1054-7. PubMed ID: 9067270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen withdrawal inhibits tumor growth and is associated with decrease in angiogenesis and VEGF expression in androgen-independent CWR22Rv1 human prostate cancer model.
    Cheng L; Zhang S; Sweeney CJ; Kao C; Gardner TA; Eble JN
    Anticancer Res; 2004; 24(4):2135-40. PubMed ID: 15330153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the antiangiogenic effect of Taxol in a human epithelial ovarian carcinoma cell line.
    Hata K; Osaki M; Dhar DK; Nakayama K; Fujiwaki R; Ito H; Nagasue N; Miyazaki K
    Cancer Chemother Pharmacol; 2004 Jan; 53(1):68-74. PubMed ID: 14569416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclooxygenase-2 promotes prostate cancer progression.
    Fujita H; Koshida K; Keller ET; Takahashi Y; Yoshimito T; Namiki M; Mizokami A
    Prostate; 2002 Nov; 53(3):232-40. PubMed ID: 12386924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteration of the vascular endothelial growth factor and angiopoietins-1 and -2 pathways in transitional cell carcinomas of the urinary bladder associated with tumor progression.
    Quentin T; Schlott T; Korabiowska M; Käthei N; Zöller G; Glaser F; Kunze E
    Anticancer Res; 2004; 24(5A):2745-56. PubMed ID: 15517881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Castration resistant prostate cancer is associated with increased blood vessel stabilization and elevated levels of VEGF and Ang-2.
    Tomić TT; Gustavsson H; Wang W; Jennbacken K; Welén K; Damber JE
    Prostate; 2012 May; 72(7):705-12. PubMed ID: 21809353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significant decrease in angiopoietin-1 and angiopoietin-2 after radical prostatectomy in prostate cancer patients.
    Caine GJ; Ryan P; Lip GY; Blann AD
    Cancer Lett; 2007 Jun; 251(2):296-301. PubMed ID: 17240049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression pattern of angiogenic factors and prognosis after hepatic resection in hepatocellular carcinoma: importance of angiopoietin-2 and hypoxia-induced factor-1 alpha.
    Wada H; Nagano H; Yamamoto H; Yang Y; Kondo M; Ota H; Nakamura M; Yoshioka S; Kato H; Damdinsuren B; Tang D; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Nakamori S; Sakon M; Dono K; Wakasa K; Monden M
    Liver Int; 2006 May; 26(4):414-23. PubMed ID: 16629644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transition of an androgen-dependent human prostate cancer cell line into an androgen-independent subline is associated with increased angiogenesis.
    Gustavsson H; Welén K; Damber JE
    Prostate; 2005 Mar; 62(4):364-73. PubMed ID: 15389782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stage-specific characterization of the vascular endothelial growth factor axis in prostate cancer: expression of lymphangiogenic markers is associated with advanced-stage disease.
    Kaushal V; Mukunyadzi P; Dennis RA; Siegel ER; Johnson DE; Kohli M
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):584-93. PubMed ID: 15701844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of bFGF, VEGF and c-met and their correlation with microvessel density and progression in prostate carcinoma.
    Strohmeyer D; Strauss F; Rössing C; Roberts C; Kaufmann O; Bartsch G; Effert P
    Anticancer Res; 2004; 24(3a):1797-804. PubMed ID: 15274358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiopoietin-2 levels in the hepatic vein as a useful predictor of tumor invasiveness and prognosis in human hepatocellular carcinoma.
    Kuboki S; Shimizu H; Mitsuhashi N; Kusashio K; Kimura F; Yoshidome H; Ohtsuka M; Kato A; Yoshitomi H; Miyazaki M
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e157-64. PubMed ID: 17931370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue.
    Joseph IB; Nelson JB; Denmeade SR; Isaacs JT
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2507-11. PubMed ID: 9815654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor vessel biology in pediatric intracranial ependymoma.
    Wagemakers M; Sie M; Hoving EW; Molema G; de Bont ES; den Dunnen WF
    J Neurosurg Pediatr; 2010 Apr; 5(4):335-41. PubMed ID: 20367336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibitory effects of cyclooxygenase-2 inhibitor celecoxib on growth and angiogenesis of human liver cancer HepG2 cell xenografts in small nude mice].
    Zuo CH; Li ZR; Zhou X; Ouyang YZ; Zhou ZY; Zeng L
    Ai Zheng; 2006 Apr; 25(4):414-20. PubMed ID: 16613672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor expression and tumor angiogenesis are regulated by androgens in hormone responsive human prostate carcinoma: evidence for androgen dependent destabilization of vascular endothelial growth factor transcripts.
    Stewart RJ; Panigrahy D; Flynn E; Folkman J
    J Urol; 2001 Feb; 165(2):688-93. PubMed ID: 11176459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.